UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 69

Sortiert nach

Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1)

Bioorganic & medicinal chemistry, 2008-08, Vol.18 (15), p.4438-4441

2008

Volltextzugriff (PDF)

Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)

Bioorganic & medicinal chemistry letters, 2009-06, Vol.19 (11), p.2924-2927

2009

Volltextzugriff (PDF)

Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13)

Bioorganic & medicinal chemistry letters, 2005-02, Vol.15 (4), p.1101-1106

2005

Volltextzugriff (PDF)

Core exploration in optimization of chemokine receptor CCR4 antagonists

Bioorganic & medicinal chemistry letters, 2007-02, Vol.17 (3), p.679-682

2007

Volltextzugriff (PDF)

Inhibitors of human mitotic kinesin Eg5: Characterization of the 4-phenyl-tetrahydroisoquinoline lead series

Bioorganic & medicinal chemistry letters, 2006-04, Vol.16 (8), p.2095-2100

2006

Volltextzugriff (PDF)

Dihydropyrazolopyrimidines containing benzimidazoles as KV1.5 potassium channel antagonists

Bioorganic & medicinal chemistry letters, 2009-09, Vol.19 (18), p.5469-5473

2009

Volltextzugriff (PDF)

Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design

Journal of medicinal chemistry, 2021-10, Vol.64 (19), p.14247-14265

2021

Volltextzugriff (PDF)

Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists

Bioorganic & medicinal chemistry letters, 2006-02, Vol.16 (4), p.989-994

2006

Volltextzugriff (PDF)

Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold

Bioorganic & medicinal chemistry letters, 2006-01, Vol.16 (2), p.395-399

2006

Volltextzugriff (PDF)

Trends in Kinase Selectivity: Insights for Target Class-Focused Library Screening

Journal of medicinal chemistry, 2011-01, Vol.54 (1), p.54-66

2011

Volltextzugriff (PDF)

Abstract 5789: Discovery of clinical candidate BMS-986158, an oral BET inhibitor, for the treatment of cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5789-5789

2018

Volltextzugriff (PDF)

Discovery of (( S )-5-(Methoxymethyl)-7-(1-methyl-1 H -indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5- a ]pyrimidin-6-yl)(( S )-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone As a Potent and Selective I Kur Inhibitor

Journal of medicinal chemistry, 2012-04, Vol.55 (7), p.3036-3048

2012

Volltextzugriff (PDF)

Dihydropyrazolopyrimidines containing benzimidazoles as K(V)1.5 potassium channel antagonists

Bioorganic & medicinal chemistry letters, 2009-09, Vol.19 (18), p.5469-5473

2009

Volltextzugriff (PDF)

Benzo[ d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)—Hit to Lead studies

Bioorganic & medicinal chemistry letters, 2009-09, Vol.19 (17), p.5063-5066

2009

Volltextzugriff (PDF)

Dimethyl-diphenyl-propanamide Derivatives As Nonsteroidal Dissociated Glucocorticoid Receptor Agonists

Journal of medicinal chemistry, 2010-12, Vol.53 (23), p.8241-8251

2010

Volltextzugriff (PDF)

Modulation of cofilin phosphorylation by inhibition of the Lim family kinases

Bioorganic & medicinal chemistry letters, 2012-09, Vol.22 (18), p.5995-5998

2012

Volltextzugriff (PDF)

Dihydropyrazolopyrimidine inhibitors of K(V)1.5 (I(Kur))

Bioorganic & medicinal chemistry letters, 2008-12, Vol.18 (24), p.6381-6385

2008

Volltextzugriff (PDF)

Small Molecule Antagonist of Leukocyte Function Associated Antigen-1 (LFA-1): Structure−Activity Relationships Leading to the Identification of 6-((5S,9R)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic Acid (BMS-688521)

Journal of medicinal chemistry, 2010-05, Vol.53 (9), p.3814-3830

2010

Volltextzugriff (PDF)

Dihydropyrazolopyrimidines containing benzimidazoles as Kv1.5 potassium channel antagonists

Bioorganic & medicinal chemistry letters, 2009-09, Vol.19 (18), p.5469-5473

2009

Volltextzugriff (PDF)

Identification of chemokine receptor CCR4 antagonist

Bioorganic & medicinal chemistry letters, 2005-05, Vol.15 (10), p.2669-2672

2005

Volltextzugriff (PDF)

Identification of pyrrolo[2,1- f][1,2,4]triazine-based inhibitors of Met kinase

Bioorganic & medicinal chemistry, 2008-03, Vol.18 (6), p.1945-1951

2008

Volltextzugriff (PDF)

Correction to Discovery of (( S )-5-(Methoxymethyl)-7-(1-methyl-1 H -indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5- a ]pyrimidin-6-yl)(( S )-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone As a Potent and Selective I Kur Inhibitor

Journal of medicinal chemistry, 2013-09, Vol.56 (17), p.7133-7133

2013

Volltextzugriff (PDF)

Dihydropyrazolopyrimidine Inhibitors of Kv1.5 (IKur)

Bioorganic & medicinal chemistry letters, 2008-12, Vol.18 (24), p.6381-6385

2008

Volltextzugriff (PDF)

Assessing compound binding to the Eg5 motor domain using a thermal shift assay

Analytical biochemistry, 2009-09, Vol.392 (1), p.59-69

2009

Volltextzugriff (PDF)

Benzopyran sulfonamides as Kv1.5 potassium channel blockers

Bioorganic & medicinal chemistry letters, 2007-06, Vol.17 (12), p.3271-3275

2007

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(68)
Dissertationen
(1)

Sprache

Englisch
(69)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(37)
Chemistry, Medicinal
(31)
Pharmacology & Pharmacy
(31)
Biological And Medical Sciences
(30)
Medical Sciences
(30)
Chemistry
(29)
Physical Sciences
(29)
Pharmacology. Drug Treatments
(27)
Structure-Activity Relationship
(27)
Chemistry, Organic
(26)
Humans
(23)
Animals
(16)
Molecular Structure
(11)
Enzyme Inhibitors - Pharmacology
(8)
Cricetinae
(7)
Drug Design
(7)
Rats
(7)
Anticholesteremic Agents - Chemistry
(6)
Atrial Fibrillation
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1)

Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)

Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13)

Core exploration in optimization of chemokine receptor CCR4 antagonists

Inhibitors of human mitotic kinesin Eg5: Characterization of the 4-phenyl-tetrahydroisoquinoline lead series

Dihydropyrazolopyrimidines containing benzimidazoles as KV1.5 potassium channel antagonists

Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design

Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists

Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold

Trends in Kinase Selectivity: Insights for Target Class-Focused Library Screening

Abstract 5789: Discovery of clinical candidate BMS-986158, an oral BET inhibitor, for the treatment of cancer

Discovery of (( S )-5-(Methoxymethyl)-7-(1-methyl-1 H -indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5- a ]pyrimidin-6-yl)(( S )-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone As a Potent and Selective I Kur Inhibitor

Dihydropyrazolopyrimidines containing benzimidazoles as K(V)1.5 potassium channel antagonists

Benzo[ d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)—Hit to Lead studies

Dimethyl-diphenyl-propanamide Derivatives As Nonsteroidal Dissociated Glucocorticoid Receptor Agonists

Modulation of cofilin phosphorylation by inhibition of the Lim family kinases

Dihydropyrazolopyrimidine inhibitors of K(V)1.5 (I(Kur))

Small Molecule Antagonist of Leukocyte Function Associated Antigen-1 (LFA-1): Structure−Activity Relationships Leading to the Identification of 6-((5S,9R)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic Acid (BMS-688521)

Dihydropyrazolopyrimidines containing benzimidazoles as Kv1.5 potassium channel antagonists

Identification of chemokine receptor CCR4 antagonist

Identification of pyrrolo[2,1- f][1,2,4]triazine-based inhibitors of Met kinase

Correction to Discovery of (( S )-5-(Methoxymethyl)-7-(1-methyl-1 H -indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5- a ]pyrimidin-6-yl)(( S )-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone As a Potent and Selective I Kur Inhibitor

Dihydropyrazolopyrimidine Inhibitors of Kv1.5 (IKur)

Assessing compound binding to the Eg5 motor domain using a thermal shift assay

Benzopyran sulfonamides as Kv1.5 potassium channel blockers

Suchergebnisse filtern